New hope in fight against muscular dystrophy

New hope in fight against muscular dystrophy
Human heart muscle cells stained with antibodies sow dystrophin as unstained muscle.

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

An international team that includes KTH researchers Christina Al-Khalili Szigyarto and Mathias Uhlén report that they discovered how to create a variant of dystrophin that can mitigate . This could in turn lead to the development of new therapies for muscular dystrophy.

The research was published this month in Nature Medicine.

Duchenne muscular dystrophy results from a lack, or impaired function, of the protein dystrophin, a major component of muscles. Dystrophin plays a significant role in, among other things, cardiovascular functioning.

The causes a progressive degeneration process of the muscles, resulting in decreased mobility, breathing problems, heart failure and, ultimately, a premature death.

Uhlén, a professor of microbiology at KTH, says the research team demonstrated the presence of so-called native and truncated dystrophin with the help of HPA antibodies in muscle.

"Then the protein is run through a gel, extracted and sequenced by mass spectrometry," Uhlén says. "The resulting sequences of the native and the truncated dystrophin protein have been compared on the level of amino acid.

"We have been able to demonstrate that in comparison with healthy people, the patients in the study manufacture a shorter version of the despite a severe mutation in the dystrophin gene."


Explore further

Discovery one step closer to treatment for Duchenne muscular dystrophy

More information: Nicolas Wein, Adeline Vulin, Maria S Falzarano, Christina Al-Khalili Szigyarto, Baijayanta Maiti, Andrew Findlay, Kristin N Heller, Mathias Uhlén, Baskar Bakthavachalu, Messina, Giuseppe Vita, Chiara Passarelli, Francesca Gualandi, Steve Wilton, Louise R Rodino-Klapac, Lin Yang, Diane M Dunn, Daniel R Schoenberg, Robert B Weiss, Michael T Howard, Alessandra Ferlini & Kevin M Flanigan, "Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice," Nature Medicine (2014) DOI: 10.1038/nm.3628, Received 31 January 2014 Accepted 05 June 2014 Published online 10 August 2014
Journal information: Nature Medicine

Citation: New hope in fight against muscular dystrophy (2014, August 22) retrieved 21 October 2019 from https://medicalxpress.com/news/2014-08-muscular-dystrophy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more